Okamoto’s Zero‑Cost Options Signal Axe Compute’s AI‑Powered Growth Boost
Insider Okamoto’s zero‑cost option grant signals Axe Compute’s shift toward AI‑powered oncology, backing a 152% share rally and a $12 M pipeline—can the firm hit its $7.5 M revenue target?
4 minutes to read